SMi is proud to present their 6th annual Antibodies and Antibody Drug Conjugates conference on the 9th-10th of April 2018.
Antibodies and antibody drug conjugates (ADCs) have the potential to make a groundbreaking impact upon medicinal therapies, diagnostics and characterization of diseases. There is massive potential for ADCs to be used in the development of targeted solid tumour therapies, due to their ability to act as precisely and effectively on target antigens.
Key topics that will be covered in the upcoming event include: fragment drug conjugates, ADC payloads, site-selective ADCs/ site-specific conjugation and the best linker and warhead combinations.
The full speaker line-up and conference agenda is available at http://www.adcsummit.com/benth
For more information visit the website at http://www.adcsummit.com/benth or contact the team on email: firstname.lastname@example.org or call +44 (0) 207 827 6012
Journal: Clinical Immunology, Endocrine & Metabolic Drugs
EBook: Antibodies Applications and New Developments
SMi Group announces the 9th Annual RNA Therapeutics Conference in London on February 21st – 22nd 2018.
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.http://bit.ly/2xtvCH1
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and evaluate with key industry leaders the lessons they’ve learnt whilst developing an RNA therapeutic. The full speaker line-up and conference agenda is available at http://www.therapeutics-rna.com/bnths
For more information visit the website at http://www.therapeutics-rna.com/bnths or contact the team on email: email@example.com or call +44 (0) 207 827 6012
Journal: Current Pharmaceutical Design
EBook: Frontiers in RNAi
Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018.
The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders from Nemesis Bioscience, ABAC Therapeutics, Oppilotech, Gladius Pharmaceuticals, Pew Charitable Trusts, Blueberry Therapeutics, UNT Health Science Center, ContraFect, SCYNEXIS; and government bodies such as MHRA and DNDi. The full speaker line-up and conference agenda is available at http://www.superbugssuperdrugs.com/bentham
Relevant Journal: Anti-Infective Agents
Relevant EBook: Frontiers in Anti-Infective Drug Discovery
SMi Group is thrilled to present the 2nd Annual 3D Cell Culture conference, taking place on 21st & 22nd February 2018 in London, UK.
Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK. 3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields, such as 3D bioprinting and microfluidics. The 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models, organoids, organ-on-a-chip technologies, Ipsc advances and CRISPR technology. Notable speakers on the agenda for 2018 will include experts from Aurelia Bioscience, ReInnervate Limited, Cell & Gene Therapy Catapult, Novartis Institutes for Biomedical Research, Kugelmeiers , Immunocore, GSK, UK Regenerative Medicine Platform, TissUse GmbH, Jellagen and more! The full speaker line-up and detailed agenda is available at http://www.3D-CellCulture.com/bentham
Relevant Journal: Current Biotechnology
Relevant EBook: Advances in Biotechnology
Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017.
Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates. As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.
For more information visit the website at http://www.superbugs-usa.com/bentham or contact the team on email: firstname.lastname@example.org or call +44 (0)20 7827 6000
Journal: Anti-Infective Agents
EBook: Frontiers in Anti-Infective Drug Discovery
SMi is proud to present the return of their 9th annual Social Media in the Pharmaceutical Industry conference to London from 18th January – 19th January 2017.
Gathering a unique audience of senior industry innovators in healthcare and digital marketing including AbbVie, Accenture, Creation, MHRA, MSD, GE Healthcare, Janssen, Lundbeck, and Pfizer, SMi Group’s sell-out show Social Media in the Pharmaceutical Industry returns to London on 18-19 January 2017.
The two-day conference will provide a platform for senior marketing practitioners to capture the latest trends and technologies, learn from practical case studies and benchmark best practice to maximise digital strategy. Day 1 will address topics on social listening skills for adapting to patient requirements, digital strategy, patient engagement, and creating content to leverage your branding; whilst Day 2 will explore advancements in technology including mHealth apps and their effect on the industry, regulatory updates and social networking for HCPs.
Featured speakers include:
- Daniel Ghinn, Founder & CEO, Creation Healthcare
- Julie O’Donnell, Head of Global Customer Interaction Management, Lundbeck
- Phil Tregunno, Signal Management Unit Manager, WEB-RADR Project Lead, MHRA
- Thibaud Guymard, Head of Digital Services, MSD
- Doris Casares, Communications Director, Medicines for Europe
- Scott Gavin, Regional Lead, Digital Centre of Excellence / Digital Services, Pfizer
- Dimithri Wignarajah, Head of Content & Social Media, GE Healthcare Life Sciences
The event will also feature two pre-conference workshops hosted by Stinesorensen Lundbeck and the Conversationalist Agency.
Register at www.social-media-pharma.com/bentham
SMi Group’s 7th annual Biosimilars Europe conference returns to London this September!
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access.
Created with a top panel of industry thought leaders, this year’s event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments.
Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development. The notable speaker line-up includes: Boehringer Ingelhei, Merck, Lupin Ltd, Bristows, Austrian Agency for Health and Food Safety + many more!
For details or to register, visit the website at http://www.biosimilars-europe.com/bentham or contact the team at +44(0) 207827 6000, email: email@example.com
SMi proudly presents the return of the 5th annual Cancer Vaccines conference to London in 2016.
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2016 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 5th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more
Join us this September for strategic direction on vaccine commercialisation and arm yourself with the key requirements and tools for successful vaccine development through informed guidance delivered by a top panel of speakers including Vaccinogen Inc, MSD, Genentech, Northwest Biotherapeutics, and more!
For details or to register, visit the website at www.cancervaccinesevent.com/bentham or contact the team at +44(0) 207827 6000, email: firstname.lastname@example.org
SMi is thrilled to announce the return of its 3rd annual conference, Allergies, taking place on 6th and 7th July 2016 in Central London UK.
Created with a top panel of industry thought leaders Allergies 2016 will capture expert insights by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostics, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus much more. Through strategic direction and regulatory guidance, the programme will strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes. Featured speakers include: MHRA, Stallergenes Greer, HAL Allergy, Inflamax Research Inc , Allergy Therapeutics, Danone, Nestle, Nippon Medical School + many more!
For details visit http://www.allergies-event.com/bentham
SMi is thrilled to announce the return of its 4th annual conference “Lyophilisation Europe” taking place on 4th and 5th July in London, UK.
With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining drug quality and stability. Innovation and efficiency is requested at every level making Lyophilisation Europe 2016, the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to a competitive growing industry. Aimed at an audience of Senior Scientists and Heads of Pharmaceutical Engineering, Lyophilisation Europe 2016 will provide a focal point for the industry to discuss the latest advancements in pharmaceutical freeze drying, welcoming expertise from the likes of Boehringer Ingelheim, GSK, Sanofi and more.
For details visit the event website at http://www.lyophilisation-europe.com/bentham